Skip to main content
TipRanks
Go Ultimate75% OFF

Atrium Therapeutics, Inc. (RNA) Ratios

25 Followers

Atrium Therapeutics, Inc. Ratios

RNA's free cash flow for Q3 2026 was $-25.78M. For the 2026 fiscal year, RNA's free cash flow was decreased by $-415.00K and operating cash flow was $-25.37M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio6.5315.737.5812.0013.86
Quick Ratio6.5315.737.5812.0013.86
Cash Ratio6.462.242.296.5610.80
Solvency Ratio-1.07-2.30-1.64-2.84-2.54
Operating Cash Flow Ratio-0.98-3.07-1.48-2.63-3.20
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 201.78M$ 1.40B$ 483.52M$ 562.22M$ 364.99M
Leverage Ratios
Debt-to-Assets Ratio0.010.000.020.020.03
Debt-to-Equity Ratio0.020.000.020.020.03
Debt-to-Capital Ratio0.020.000.020.020.03
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.341.101.261.111.12
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.210.060.130.200.28
Net Debt to EBITDA3.480.570.751.862.63
Profitability Margins
Gross Profit Margin100.00%100.00%78.02%84.96%-984.95%
EBIT Margin-412.64%-3477.43%-2464.41%-1939.65%-1265.83%
EBITDA Margin-410.91%-3451.96%-2442.44%-1924.61%-1258.97%
Operating Profit Margin-412.58%-3477.43%-2464.41%-1939.65%-1265.83%
Pretax Profit Margin-412.64%-2957.71%-2219.87%-1886.33%-1265.38%
Net Profit Margin-411.88%-2957.71%-2219.87%-1886.33%-1265.38%
Continuous Operations Profit Margin-411.88%-2957.71%-2219.87%-1886.33%-1265.38%
Net Income Per EBT99.82%100.00%100.00%100.00%100.00%
EBT Per EBIT100.02%85.05%90.08%97.25%99.96%
Return on Assets (ROA)-27.55%-20.61%-33.76%-27.24%-27.60%
Return on Equity (ROE)-36.99%-22.62%-42.38%-30.10%-30.94%
Return on Capital Employed (ROCE)-32.47%-25.85%-43.00%-30.48%-29.67%
Return on Invested Capital (ROIC)-31.92%-25.78%-42.72%-30.32%-29.54%
Return on Tangible Assets-27.55%-20.61%-33.76%-27.24%-27.60%
Earnings Yield-30.38%-9.93%-32.12%-15.03%-11.98%
Efficiency Ratios
Receivables Turnover0.000.391.112.3810.36
Payables Turnover0.000.000.240.3036.06
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover3.380.600.570.610.60
Asset Turnover0.070.010.020.010.02
Working Capital Turnover Ratio0.000.010.020.020.03
Cash Conversion Cycle0.00945.31-1201.13-1066.9325.10
Days of Sales Outstanding0.00945.31329.23153.3435.22
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.000.001530.361220.2610.12
Operating Cycle0.00945.31329.23153.3435.22
Cash Flow Ratios
Operating Cash Flow Per Share-2.40-2.70-1.63-2.61-2.29
Free Cash Flow Per Share-2.49-2.76-1.69-2.67-2.38
Dividend Paid and CapEx Coverage Ratio-28.46-42.58-28.16-48.27-25.35
Capital Expenditure Coverage Ratio-28.46-42.58-28.16-48.27-25.35
Operating Cash Flow Coverage Ratio-11.20-44.24-12.09-12.75-8.08
Operating Cash Flow to Sales Ratio-2.21-27.61-12.45-14.77-10.17
Free Cash Flow Yield-16.87%-9.49%-18.66%-12.02%-10.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.29-10.07-3.11-6.65-8.34
Price-to-Sales (P/S) Ratio13.56297.7769.12125.49105.59
Price-to-Book (P/B) Ratio1.222.281.322.002.58
Price-to-Free Cash Flow (P/FCF) Ratio-5.93-10.54-5.36-8.32-9.99
Price-to-Operating Cash Flow Ratio-6.14-10.78-5.55-8.49-10.39
Price-to-Earnings Growth (PEG) Ratio0.0014.650.24-0.39-0.21
Enterprise Value Multiple0.18-8.06-2.08-4.66-5.76
Enterprise Value-13.90M3.03B485.53M827.77M676.02M
EV to EBITDA0.18-8.06-2.08-4.66-5.76
EV to Sales-0.75278.2250.7989.7472.49
EV to Free Cash Flow0.33-9.85-3.94-5.95-6.86
EV to Operating Cash Flow0.34-10.08-4.08-6.07-7.13
Tangible Book Value Per Share12.1112.776.8611.089.21
Shareholders’ Equity Per Share12.1112.776.8611.089.21
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share1.090.100.130.180.23
Net Income Per Share-4.48-2.89-2.91-3.34-2.85
Tax Burden1.001.001.001.001.00
Interest Burden1.000.850.900.971.00
Research & Development to Revenue2.8927.8619.9816.3110.85
SG&A to Revenue2.247.915.674.092.81
Stock-Based Compensation to Revenue0.414.714.002.941.83
Income Quality0.830.930.560.780.80

Currency in USD